Dermira, Inc. (DERM) financial statements (2021 and earlier)

Company profile

Business Address 275 MIDDLEFIELD ROAD
MENLO PARK, CA 94025
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments31355125221597
Cash and cash equivalents1052964210755
Short-term investments20825521010742
Receivables 021 7
Inventory, net of allowances, customer advances and progress billings8    
Inventory8    
Other undisclosed current assets1461131
Total current assets:335557284217105
Noncurrent Assets
Property, plant and equipment11100
Long-term investments and receivables3 25166
Long-term investments3 25166
Intangible assets, net (including goodwill)22224
Goodwill11111
Intangible assets, net (excluding goodwill)11114
Restricted cash and investments1    
Other noncurrent assets21112
Total noncurrent assets:9429573
TOTAL ASSETS:344561313222178
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3940312614
Accounts payable16151496
Accrued liabilities232517176
Employee-related liabilities    2
Deferred revenue and credits54  
Other undisclosed current liabilities 60  (2)
Total current liabilities:39105352612
Noncurrent Liabilities
Long-term debt and lease obligation33279  2
Long-term debt, excluding current maturities33279  2
Liabilities, other than long-term debt126301111
Deferred revenue and credits25301010
Deferred tax liabilities, net 0001
Other liabilities1100 
Other undisclosed noncurrent liabilities281    
Total noncurrent liabilities:315306301113
Total liabilities:353411653625
Stockholders' equity
Stockholders' equity attributable to parent(9)150247185154
Common stock00000
Additional paid in capital736703498347236
Accumulated other comprehensive loss(0)(0)(0)(0)(0)
Accumulated deficit(745)(553)(250)(161)(83)
Total stockholders' equity:(9)150247185154
TOTAL LIABILITIES AND EQUITY:344561313222178

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues4252377
Revenue, net523 7
Cost of revenue
(Cost of Goods and Services Sold)
(1)    
Gross profit:4152377
Operating expenses(256)(305)(113)(87)(39)
Other undisclosed operating income1    
Operating loss:(214)(300)(91)(80)(32)
Nonoperating income85   
Interest and debt expense(16)(8) (0)(0)
Loss from continuing operations before equity method investments, income taxes:(222)(303)(91)(80)(32)
Other undisclosed income from continuing operations before income taxes  210
Loss from continuing operations before income taxes:(222)(303)(89)(79)(32)
Income tax expense (benefit)0  1(0)
Net loss available to common stockholders, diluted:(222)(303)(89)(78)(32)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(222)(303)(89)(78)(32)
Comprehensive loss:(222)(303)(89)(78)(32)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)0(0)
Comprehensive loss, net of tax, attributable to parent:(221)(303)(89)(78)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: